Action | Date | Index | Provider |
---|---|---|---|
Join | 2024 | Pharma, Biotech & Life Science | Saudi Exchange Co |
Join | 2024 | Tadawul All Share Index (TASI) | Saudi Exchange Co |
Middle East Pharmaceutical Industries Co. |
Second Industrial City, PO Box 3800, Riyadh 14331, Kingdom of Saudi Arabia |
T : +966 11 2653948 |
F : +966 11 2654723 |
www.avalonpharmaceutical.com |
investor.relations@avalon.com.sa |
Title | Name | As Of |
---|---|---|
Chairman: | Ahmed Altabbaa | 2022 |
Deputy Chairman: | Hisham Attar | 2023 |
Managing Director: | Mohammed Al Ghannam | 2022 |
Board Member: | Faisal Aljaman | 2022 |
Omar Al Jaroudi | 2023 |
Date | Title | File |
---|---|---|
2024 | AVALON PHARMA Quarterly Financials Report Q2 2024 | |
2024 | AVALON PHARMA Quarterly Financials Report Q1 2024 | |
2024 | Avalon delivers strong start to 2024 with a remarkable 37% increase in revenue, high profitability and substantial rise in net profit | |
2024 | AVALON PHARMA Annual Financials Report 2023 | |
2024 | Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces the Final Offer Price | |
2024 | Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces its IPO Offer Price Range and Commencement of Institutional Book Building | |
2024 | Middle East Pharmaceutical Industries Company (“Avalon Pharma”) Announces its Intention to Float on the Saudi Exchange’s Main Market | |
2023 | AVALON PHARMA Quarterly Financials Report Q2 2023 | |
2023 | AVALON PHARMA Annual Financials Report 2022 | |
2022 | AVALON PHARMA Annual Financials Report 2021 | |
2021 | AVALON PHARMA Annual Financials Report 2020 |